Rapid ASPECTS
Overview
Rapid ASPECTS, developed by iSchemaView (now operating as RapidAI), is a computer-aided diagnosis (CADx) software device designed to assist clinicians in the assessment and characterization of brain tissue abnormalities using CT image data. It automatically registers images, segments, and analyzes ASPECTS (Alberta Stroke Program Early CT Score) Regions of Interest (ROIs). The software extracts image data for these ROIs to provide analysis and computer analytics based on morphological characteristics. An artificial intelligence algorithm then synthesizes these features into a single ASPECT Score. Rapid ASPECTS is indicated for the evaluation of adult patients presenting for diagnostic imaging workup with known Middle Cerebral Artery (MCA) or Internal Carotid Artery (ICA) occlusion, to assess the extent of disease. It provides information useful in characterizing early ischemic brain tissue injury during image interpretation, typically within 6 hours. The tool aims to improve clinician diagnostic accuracy, increase reader reliability, and reduce intra-reader variability, ultimately helping physicians make faster clinical decisions for patients with large vessel occlusions (LVOs) and determine eligibility for thrombectomy.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated ASPECTS score generation for non-contrast CT scans
- Visualization of regions of asymmetry and ischemic change
- Improved clinician diagnostic accuracy (shown to improve by 10%)
- Increased reader reliability and reduced intra-reader variability
- Fast results delivery (under 2 minutes)
- Assists in determining thrombectomy eligibility
- Utilizes clinically validated machine-learning algorithms
- Creates high-quality images from non-contrast CT studies
- Delivers results via PACS, email, and mobile/web applications
- Provides comparative analysis to the ASPECTS standard of care radiologist assessment
Use Cases
- Assessment and characterization of brain tissue abnormalities using CT image data
- Evaluation of adult patients with known MCA or ICA occlusion
- Determining eligibility for mechanical thrombectomy in stroke patients
- Expediting time between CT and CTA scans with prompt LVO notifications (as part of the RapidAI platform)
- Improving patient outcomes in acute stroke care through faster interventions
- Aiding in patient selection for stroke clinical trials (e.g., DAWN and DEFUSE 3)
What Physicians Need to Know
Rapid ASPECTS can help non-neuroradiologists improve their ASPECT scoring of non-contrast CT (NCCT) scans, making scores more consistent and accurate, especially when neuroradiologists are not immediately available. The automated score, combined with a physician's review, can improve the accuracy of ASPECTS score calculation. Physicians can adjust the scores based on other clinical factors through the Rapid Platform User Interface. The system can help identify areas of irreversible brain injury and determine a patient's eligibility for thrombectomy.
RapidAI is an AI-enabled software platform that facilitates the viewing, processing, and analysis of CT imaging to aid clinicians in assessing patients, including those with suspected stroke. It builds on the original RAPID software, which was developed to automate and expedite the postprocessing of CT perfusion imaging. The platform offers an end-to-end portfolio of advanced cerebrovascular imaging analysis products, including Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid CTP, and Rapid MRI.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. |
| Deployment | Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). |
| Mobile App | Real-time collaboration and alerts for urgent cases |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Neurology, Radiology |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-01-19 | K232156 510(k) | Rapid ASPECTS |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Rapid ASPECTS
Videos
Product demos, reviews, and walkthroughs for Rapid ASPECTS.
RapidAI | AI-Driven Radiology Advancements with Vivek Yedavalli, MD
Frequently Asked Questions
Compare Rapid ASPECTS
VS
VS
VS
VS







